Targeting Cytokines in GVHD Therapy. - Wikidata - wikimedia - TriplyDB

Targeting Cytokines in GVHD Therapy.

Targeting Cytokines in GVHD Therapy.

http://www.wikidata.org/entity/Q38640486

about

Targeting Cytokines in GVHD Therapy.

http://www.wikidata.org/entity/Q38640486

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Targeting Cytokines in GVHD Therapy.

@en

type

label

Targeting Cytokines in GVHD Therapy.

@en

prefLabel

Targeting Cytokines in GVHD Therapy.

@en

P1433

Q38640486-63DC140C-7310-4A43-931A-C8C66728F226

P1476

Q38640486-EFBB98B7-415C-417A-9E6F-A4FEACCEAE25

P2093

Q38640486-43BBB21D-99A2-46A0-80EC-2AF2414802AD

Q38640486-45596E42-D4DC-49AC-BC6D-F714A3B614CB

Q38640486-45F93B2D-7FD9-43A9-8423-42D282362AC4

P2860

Q38640486-047C643D-9A78-4E5B-9435-F7C866CD8E4E

Q38640486-061EDD15-869B-4891-8693-4702BE87D3C2

Q38640486-07188683-F511-4844-93F9-C92EB73E3C1B

Q38640486-0D4BFC64-14FC-4CEF-A8C7-9987F59ECA34

Q38640486-0FAFB106-D5F3-4EFA-B05B-B1BC16443CEE

Q38640486-11C329BE-612A-4266-A997-CA4C9E408D30

Q38640486-11DB5CA5-4C56-44DE-A18C-505681CA4C2F

Q38640486-14FCE6F3-28D9-4A2B-A126-CECE357B37A2

Q38640486-16DC1BED-485A-41E7-8779-915476EF8CA3

Q38640486-17236CAB-3555-4846-842B-EAB2F27F07AA

P304

Q38640486-F454D0F3-D45A-4B54-8214-E9E688871145

P31

Q38640486-213D2DDA-7EF2-4FF9-895A-E4184B2D1A98

P433

Q38640486-1F14D5D7-E445-46D4-A2A2-B6461440E36B

P478

Q38640486-D75CB5E4-DDB9-4250-B6FF-76B5D112E738

P577

Q38640486-D95CF769-9C58-498E-B26C-5C3CA40344DC

P698

Q38640486-55786D86-2681-48F8-9090-92F6FD8BD5FD

P932

Q38640486-E2A5F671-5102-4738-8129-68F22E1E649A

P1433

Journal of immunology research and therapy

P1476

Targeting Cytokines in GVHD Therapy.

@en

P2093

Hemn Mohammadpour

http://www.w3.org/2001/XMLSchema#string

Sandeep Kumar

http://www.w3.org/2001/XMLSchema#string

Xuefang Cao

http://www.w3.org/2001/XMLSchema#string

P2860

Human interleukin-10 can directly inhibit T-cell growth

Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease

Innate lymphoid cells in graft-versus-host disease

IL-17 and Th17 Cells

Cytokines in Graft-versus-Host Disease

Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells

Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells.

Increased T follicular helper cells and germinal center B cells are required for cGVHD and bronchiolitis obliterans

Interleukin 15: biology and relevance to human disease.

Th17/Treg ratio in human graft-versus-host disease.

P304

90-99

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2017-06-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28819653

http://www.w3.org/2001/XMLSchema#string

P932

5557058

http://www.w3.org/2001/XMLSchema#string